A. Mark Fendrick, M.D. is a Professor of Internal Medicine in the School of Medicine and a Professor of Health Management and Policy in the School of Public Health at the University of Michigan. Dr. Fendrick received a bachelor’s degree in economics and chemistry from University of Pennsylvania and his medical degree from Harvard Medical School. Dr. Fendrick completed his residency in internal medicine at the University of Pennsylvania where he was a fellow in the Robert Wood Johnson Foundation Clinical Scholars Program. He currently directs the Center for Value-Based Insurance Design at the University of Michigan [www.vbidcenter.org], the leading advocate for development, implementation, and evaluation of innovative health benefit plans.
Dr. Fendrick’s research focuses on the clinical and economic assessment of medical interventions with special attention to how technological innovation influences clinical practice, benefit design, and health care systems. He has authored over 200 articles and book chapters and lectures frequently on the quality and cost implications of medical care to diverse audiences around the world. Dr. Fendrick remains clinically active in the practice of general internal medicine. He is the Co-editor in chief of the American Journal of Managed Care and is an editorial board member for 3 additional peer-reviewed publications. His perspective and understanding of clinical and economic issues have fostered collaborations with numerous government agencies, health plans, professional societies, and health care companies. He serves on the Medicare Coverage Advisory Committee. In 2009, he was named one of the “20 people who make healthcare better” by HealthLeaders Media for the creation and implementation of value-based insurance design.
HMP612: Medical Management of Disease
M.D., Harvard Medical School, 1987
B.A. (Summa Cum Laude), Economics/Chemistry, University of Pennsylvania, 1982
Research Interests & Projects
Dr. Fendrick's research focuses on the clinical and economic assessment of medical interventions with special attention to how technological innovation influences clinical practice, benefit design, and health care systems. He has performed economic analyses of new interventions for several common conditions including: laparoscopic cholecystectomy, gastroesophageal reflux disease, arthritis/inflammatory conditions, viral infections, acute myocardial infarction, pediatric vaccinations, and cancer screening. These analyses are supplemented by research describing how outcomes research data can be incorporated into clinical practice.
Search PubMed for publications by A. Fendrick >>
Fendrick AM, Smith DG, Chernew ME (2010). Applying Value-Based Insurance Design To Low-Value Health Services Health Affairs, 29(11), 2017-2021.
Chernew ME, ,Juster IA, Shah MR, Wegh A, Rosenberg SN Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. (2010). Evidence that Value-based Insurance Can Be Effective Health Affairs, Web Exclusive.
Chernew M, Gibson TB, Fendrick AM. (2010). Trends in Patient Cost Sharing for Clinical Services Used as Quality Indicators. J Gen Intern Med, January
Fendrick AM, Chernew ME, Levi GW. (2009). Value-Based Insurance Design: Embracing Value Over Cost Alone. Am J Manag Care, Dec., S277.
Fendrick AM, Chernew ME. (2009). Value Based Insurance Design: Maintaining a Focus on Health in an Era of Cost Containment. Am J Manag Care., 15(6)
Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM. (2008). Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med, Aug;23(8), 1131-6.
Chernew ME, Rosen AB, Fendrick AM. (2007). Value-Based Insurance Design Health Affairs, 26 (2), w195-w203.
Fendrick AM, Chernew ME. (2007). Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans J Gen Intern Med, Jun 22(6), 890-1.
Fendrick, A.M., Smith, D.G., Chernew, M.E., et al. (2001). A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost. American Journal of Managed Care, 7, 861-867.
Fendrick AM, Chernew ME. (2007). Fiscally responsible, clinically sensitive" cost sharing: contain costs while preserving quality. Am J Manag Care, Jun;13(6 Pt 2), 325-7.
Society of General Internal Medicine
American College of Physicians
International Society for Technology Assessment in Health Care (Board of Directors 1995-1998)
1996 - Present: International Society for Pharmacoeconomics and Outcomes Research (Board of Directors 2000-2002)
2008 - Present: Co-Chair, Michigan Cardiovascular Alliance, Michigan Department of Community Health
Member, American Federation for Clinical Research